TANG CAPITAL MANAGEMENT, LLC 13D and 13G filings for Crescent Biopharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-10-09 4:15 pm Purchase | 2025-10-02 | 13G | Crescent Biopharma, Inc. CBIO | TANG CAPITAL MANAGEMENT, LLC | 700,000 5.040% | 700,000 (New Position) | Filing |